摘要
目的探析晚期恶性肿瘤患者凝血功能及D-二聚体水平检测的临床价值。方法方便选取该院2014年8月—2016年1月收治的60例晚期恶性肿瘤患者,设为研究组,同时选择60名健康体检者作为对照组,均检测凝血功能及D-二聚体水平,比较分析两组PT、TT、FIB等指标及D-二聚体水平变化。结果研究组研究组PT(14.84±0.82)s、TT(18.83±2.11)s、FIB(4.35±1.90)g/L、D-二聚体(2.39±0.04)mg/L、APTT水平(18.8±4.21)s与对照组比较差异有统计学意义,P<0.05。结论对晚期恶性肿瘤患者进行凝血功能及D-二聚体水平检测的临床价值较高,对观察肿瘤患者高凝状态具有指导意义,值得推广。
Objective The clinical value of patients with malignant blood coagulation function and D- dimer testing.Methods Convenient selection our hospital in August 2014 to January 2016 admitted 60 patients with advanced cancer patients to the study group, while 60 cases healthy people as a control group, were detected in blood coagulation and D- dimer levels, more analysis of two PT, TT, FIB and other indicators, and D-dimer levels.Results PT team group（14.84±0.82） s, TT（18.83±2.11） s, FIB（4.35 ±1.90） g/L, D-dimer（2.39±0.04） mg/L, APTT level（18.8 ±4.21） s clear difference compared with control group,（P〈0.05）. Conclusion High clinical value in patients with advanced malignancies and D- dimer coagulation test, observed in cancer patients with a hypercoagulable state significance, worthy of promotion.
出处
《中外医疗》
2016年第31期35-36,39,共3页
China & Foreign Medical Treatment
